Alice assists clients with a wide range of matters relating to the commercialisation of intellectual property rights and a broad range of regulatory and compliance issues concerning healthcare, industrial and consumer products prior to and after launch. She also assists with product safety issues, including supporting in risk management/compliance assessments.
Advising an Australia-based investment firm on its investment in a global telehealth company providing weight loss prescription services in the UK and Germany.
Advising a clinical-stage biopharmaceutical company in administration on the transfer to a purchaser of the rights to a medical device product.
Advising a MedTech university spin-out company on the drafting and negotiation of a strategic partnership with a global top-10 medical device company.
Advising Rockpool Investments on its acquisition on orthoses and clinical services provider Talar-Made Ltd.
Press releaseAdvising Essential Pharma on its acquisition of European rights to Colobreathe® from Teva Laboratories UK Limited.
Press release
EU and medicines supply issues (part two): Proposals for future measures
In part two of our article on EU and medicine supply issues we explore the key proposals outlined in pharmaceutical reform and their impact on marketing authorisation holders across the region.
作者 Alison Dennis 以及 Alice Matthews
3 / 5 观点
Corrective actions: dos and don’ts
This article sets out a summary of the key dos and don’ts for preparing for and managing corrective action in the life sciences sector.
作者
5 / 6 观点
作者